A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic Dermatitis
NCT07576023 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2026-05-08
Summary
The aim of this study is to evaluate, with clinical and biological assessment methods, the effectiveness of the tested cosmetic product applied during 4 weeks of intensive treatment and compared to a Standard Medical Care (medicine shampoo) and to a comparative cosmetic shampoo, on mild to moderate recurrent squamous states of seborrheic dermatitis.
Conditions
- Seborrheic Dermatitis
Interventions
- OTHER
-
RV5263A - WS0060
Cosmetic product Thrice weekly applications
- OTHER
-
RV5263A - LC3302
Cosmetic product Thrice weekly applications
- DRUG
-
Standard Medical Care (SMC)
Standard medical care applications
Sponsors & Collaborators
-
Pierre Fabre Dermo Cosmetique
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-04
- Primary Completion
- 2025-06-17
- Completion
- 2025-06-17
Countries
- Poland
Study Locations
More Related Trials
-
Efficacy of an Antioxidant Moisturizing Serum for Mild to Moderate Seborrheic Dermatitis
NCT07433907 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Efficacy of a Cosmetic Care in Subjects With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments
NCT07577921 ·Status: COMPLETED
-
Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis
NCT02656368 ·Status: COMPLETED ·Phase: NA
-
Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis
NCT02004860 ·Status: COMPLETED ·Phase: PHASE3
-
Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis
NCT01792713 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis
NCT02795832 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters in Adults With Mild to Moderate Atopic Dermatitis, an Exploratory Study
NCT07166497 ·Status: COMPLETED
-
Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis
NCT01385657 ·Status: COMPLETED ·Phase: PHASE1
-
The Study of CM326 in Moderate-to-severe Atopic Dermatitis
NCT05671432 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
NCT03736967 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult
NCT03830177 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
In-Use Test of a Cosmetic Product in Subjects With Chronically Itchy Scalp
NCT03630107 ·Status: COMPLETED ·Phase: NA
-
Evaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic Dermatitis
NCT03632174 ·Status: COMPLETED ·Phase: NA
-
To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis
NCT04684485 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis
NCT02732314 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
NCT04875169 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
NCT02260986 ·Status: COMPLETED ·Phase: PHASE3
-
In-Use Test With a Cosmetic Product
NCT03252730 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Quality of Life of Male and Female Adult Patients With Severe Refractory Atopic Dermatitis Treated With Dupilumab in Czech Republic
NCT05527964 ·Status: COMPLETED
-
Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)
NCT01639040 ·Status: COMPLETED ·Phase: PHASE2
-
The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.
NCT05696392 ·Status: TERMINATED ·Phase: PHASE4
-
Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients
NCT06983561 ·Status: COMPLETED
-
Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic Dermatitis
NCT01259323 ·Status: COMPLETED ·Phase: PHASE1
-
K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp
NCT01137331 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis
NCT02757729 ·Status: COMPLETED ·Phase: PHASE2